Assessing the Effect of Abstinence Period on Semen Parameters

Sponsor
Weill Medical College of Cornell University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05701163
Collaborator
(none)
100
1
1
25
4

Study Details

Study Description

Brief Summary

The goal of this study is to learn about the impact of abstinence periods on sperm quality in healthy males 20-45 years of age with no significant comorbidities who are able to produce a semen sample via masturbation. The main question it aims to answer is:

• Do shorter abstinence periods result in improved semen quality?

Participants will provide semen samples for analysis following abstinence periods of 7 days, 5 days, 2 days, 1 day, and 3 hours.

Condition or Disease Intervention/Treatment Phase
  • Other: Abstinence followed by semen sample collection.
N/A

Detailed Description

Participant Duration: Total length of time on study per subject is 14 days (including 5 days of visit required for sample production). Subjects do not need to complete the visits in order but need to document abstinence period prior to sample production. No follow up will be needed after the study.

Primary Objective: The primary objective is to examine the differences in semen analysis parameters after varying abstinence periods (7 days, 5 days, 2 days, 1 day, 3 hours).

Secondary Objectives: The secondary objective(s) is to assess changes in sperm DNA fragmentation after varying abstinence periods (7 days, 5 days, 2 days, 1 day, 3 hours).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Assessing the Effect of Abstinence Period on Semen Parameters
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Feb 1, 2025
Anticipated Study Completion Date :
Feb 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Healthy Volunteers

Healthy males with no significant comorbidities, aged 20-45 years who are able to produce a semen sample by masturbation.

Other: Abstinence followed by semen sample collection.
Abstinence is the intervention. Semen samples will be collected after abstinence periods.

Outcome Measures

Primary Outcome Measures

  1. Change in semen analysis parameters based on different abstinence periods: volume [7 days, 5 days, 2 days, 1 day, 3 hours]

    The primary objective is to examine the differences in semen analysis parameters (volume in mL) after varying abstinence periods (7 days, 5 days, 2 days, 1 day, 3 hours).

  2. Change in semen analysis parameters based on different abstinence periods: sperm concentration [7 days, 5 days, 2 days, 1 day, 3 hours]

    The primary objective is to examine the differences in semen analysis parameters (sperm concentration measured in million sperm/mL) after varying abstinence periods (7 days, 5 days, 2 days, 1 day, 3 hours).

  3. Change in semen analysis parameters based on different abstinence periods: motility [7 days, 5 days, 2 days, 1 day, 3 hours]

    The primary objective is to examine the differences in semen analysis parameters (motility measured as a percentage) after varying abstinence periods (7 days, 5 days, 2 days, 1 day, 3 hours).

Secondary Outcome Measures

  1. Change in sperm DNA fragmentation based on different abstinence periods [7 days, 5 days, 2 days, 1 day, 3 hours]

    The secondary objective(s) is to assess changes in sperm DNA fragmentation after varying abstinence periods (7 days, 5 days, 2 days, 1 day, 3 hours).

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 45 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Males, aged 20-45 years

  • Healthy, no significant comorbidities

  • Able to produce a semen sample by masturbation

  • Total sperm count ≥ 1 million sperm

  • Abnormal sperm DNA fragmentation (TUNEL assay value ≥ 20%)

Exclusion Criteria:
  • Age < 20 or > 45 years

  • Significant comorbidities, including significant cardiac, pulmonary, gastrointestinal, hematologic, or neurologic disease

  • Total sperm count < 1 million sperm

  • Aspermia (semen volume = 0)

  • Normal sperm DNA fragmentation (TUNEL assay value < 20%)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Weill Cornell Medicine New York New York United States 10065

Sponsors and Collaborators

  • Weill Medical College of Cornell University

Investigators

  • Principal Investigator: Jessica Marinaro, MD, Weill Medical College of Cornell University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT05701163
Other Study ID Numbers:
  • 21-10024093
First Posted:
Jan 27, 2023
Last Update Posted:
Jan 27, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 27, 2023